India may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

India's labour market is undergoing a structural transformation driven by the country's broader economic transition, a report by SBI Resear...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

What we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...

Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...

From nanobubble tech and agro-exports to e-waste recycling and specialty chemicals, the best Indian MSMEs across 20 categories redefined wh...

New bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...

Small and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...

Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety st...

"We had met the minister and urged him to help the MSME sector. We want the officials at the regulatory body to become facilitators for the...

ET MSME Awards 2023 is an ET Digital initiative aimed at celebrating the success of Indian MSMEs powering the economy. The awards will serv...

Union minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...

In a release last month, the Ministry of Chemicals and Fertilisers said that 55 companies had qualified for the PLI scheme for the pharmace...

Promoters can be considered for resolution of their own cos as they are exempt from section 29(A) of IBC.